Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Imaging Technique Allows Researchers To Monitor Protein Changes In Mouse Tumors
A new imaging technique can monitor, in living mice, the HER2 protein found in above-normal amounts in many cases of breast cancer as well as some ovarian, prostate and lung cancers. This new approach, once validated in mice and pending further experiments, could provide a real-time noninvasive method for identifying tumors in humans who express HER2 and who would be candidates for targeted therapy directed against this protein. It may also provide real-time information that will help clinicians optimize treatment for individual patients. The study, published in the July 2009 issue of The Journal of Nuclear Medicine, was conducted by researchers at the National Cancer Institute (NCI) and the National Institute of Biomedical Imaging and Bioengineering, both parts of the National Institutes of Health.
generic viagra online
Campaign Countdown For Voices Of Industry
The UK"s life sciences companies have just two days remaining to tell the Government what it can do to help them succeed, as medical and healthcare industry specialist MedilinkWM brings its Voices of Industry Campaign to fruition.
News of the day
PROLOR Biotech Awarded Two U.S. Patents For Its Longer-Acting Human Growth Hormone And Longer-Acting Erythropoietin
PROLOR Biotech, Inc. (OTC Bulletin Board: PBTH), formerly Modigene Inc., announced that the U. S. Patent and Trademark Office (PTO) has issued two new patents for the company"s long-acting CTP-enhanced human growth hormone (hGH-CTP) and human erythropoietin (EPO-CTP). The patents cover the composition of PROLOR"s proprietary pharmaceutical compounds as well as certain associated methods. PROLOR"s CTP technology is based on a short amino acid sequence, the Carboxyl Terminal Peptide that occurs naturally in humans. When attached to a therapeutic protein, CTP extends the time that the protein is active in the body.
Mental Health

Siemens Launches 'Decibels For Life' - New Campaign Aims For Hearing Awareness And Instrument Innovation

"Decibels for Life", the new campaign from Siemens Hearing Instruments, has been launched to maintain awareness of hearing loss. It will also champion hearing innovations that help overcome impairments leading to an improved quality of life. The ongoing campaign will address how hearing loss or wearing an inappropriate hearing instrument can mean missing out on a range of daily sounds. It will draw on everyday examples such as clinking glasses, whispered gossip or buzzing bees under the slogan, "Why miss a decibel in your life?" "The "Decibels for Life" campaign will address the issue of hearing impairment and the importance of having the right hearing instrument. Fifteen per cent of the population is diagnosed with hearing loss, but many more are not aware of how much they fail to hear," states Darren Ransley, UK Product and Marketing Manager at Siemens Hearing Instruments. "With an ageing population and growing awareness that hearing needs to be tested regularly, it is important to inform people that there are innovations that can make a real difference to quality of life." Siemens Hearing Instruments


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009